• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chaperone-assisted selective autophagy targets filovirus VP40 as a client and restricts egress of virus particles - PNAS

Mary Wilson

Well-known member
January 4, 2023
120 (2) e2210690120
https://doi.org/10.1073/pnas.2210690120

Jingjing Liang, Marija A. Djurkovic, Olena Shtanko https://orcid.org/0000-0002-9848-8870, and Ronald N.Harty

Significance

Filoviruses EBOV and MARV are zoonotic, emerging pathogens that cause sporadic and global outbreaks of severe hemorrhagic fever. As filoviruses can establish persistent infections in immune-privileged sites inaccessible to antibody therapy, and their re-emergence can result in long-term sequelae and death, identifying virus–host interactions that contribute to their transmission and pathogenesis will reveal new opportunities and targets for antiviral development and intervention. Here, we describe how the mTORC1/CASA axis functions to regulate and restrict the egress of EBOV particles by targeting the main driver of filovirus budding—the VP40 matrix protein, which may represent a new host defense strategy in the ongoing arms race between virus and host.

Abstract

The filovirus VP40 protein directs virion egress, which is regulated either positively or negatively by select VP40–host interactions. We demonstrate that host BAG3 and HSP70 recognize VP40 as a client and inhibit the egress of VP40 virus-like particles (VLPs) by promoting degradation of VP40 via Chaperone-assisted selective autophagy (CASA). Pharmacological inhibition of either the early stage formation of the VP40/BAG3/HSP70 tripartite complex, or late stage formation of autolysosomes, rescued VP40 VLP egress back to WT levels. The mechanistic target of rapamycin complex 1 (mTORC1) is a master regulator of autophagy, and we found that surface expression of EBOV GP on either VLPs or an infectious VSV recombinant virus, activated mTORC1. Notably, pharmacological suppression of mTORC1 signaling by rapamycin activated CASA in a BAG3-dependent manner to restrict the egress of both VLPs and infectious EBOV in Huh7 cells. In sum, our findings highlight the involvement of the mTORC1/CASA axis in regulating filovirus egress.

https://www.pnas.org/doi/10.1073/pnas.2210690120
 
Back
Top